NCT00660569CompletedNot Applicable
Utilization Patterns of Pulmicort HFA in Real Life Practice
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 260
- Locations
- 1
Study Overview
Brief Summary
The purpose of this study is to identify the potential issues during short and mid term utilization of Pulmicort hydro fluoroaklane (HFA) pressurized metered-dose inhaler (pMDI)and describe associated factors.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Asthmatic patients with a diagnose of at least 12 months of duration before study inclusion
- •Patients previously treated with Pulmicort CFC who have changed their treatment to Pulmicort HFA
Exclusion Criteria
- •Disability that, from investigator point of view, prevent from complying the follow up schedule
- •To have participated in any clinical study in the past 6 months
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Characteristics and Medical Resource Utilization of Postoperative PatientsPain, PostoperativeNCT03293212Jaseng Medical Foundation102
Recruiting
Not Applicable
TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma StudyPleural MesotheliomaNCT05538806NovoCure GmbH198
Unknown
Not Applicable
Clinical and Medico-economic Validation of the HEPHAI Solution.Asthma COPDNCT06099145Hephai238
Completed
Not Applicable
Evaluation of a Multi-Purpose SolutionContact Lens SolutionsNCT00710879Bausch & Lomb Incorporated180
Completed
Not Applicable
Real-World Patient Characteristics, Treatment Patterns, and Clinical Outcomes Among Patients With BRAF-Positive Metastatic MelanomaBRAF-positive Metastatic MelanomaNCT06251934Novartis Pharmaceuticals785